Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments

Behavior Genetics
Mara DierssenCristina Fillat

Abstract

Trisomy 21 or Down syndrome (DS) is a complex syndrome, of genetic origin with multiple and variable neurobiological and neuropsychological manifestations. DS patients have consistent signs of brain damage along their lives, but understanding the biology of DS is complicated due to the extraordinary heterogeneity of the phenotypic signs. Thus, treatment of DS mental retardation poses significant challenges for clinicians and scientists. The review addresses the classical pharmacological and environmental treatments and also critically reviews the new possibilities that are emerging from the exciting advances in gene or cell therapy. We describe some of the most recent developments in the field and give a sense of the prospects for future prevention and therapy.

References

May 1, 1976·The Journal of Comparative Neurology·M Marin-Padilla
Jul 1, 1978·Neuropathology and Applied Neurobiology·E K PerryB E Tomlinson
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D M HoltzmanW C Mobley
Jan 1, 1989·Exceptional Children·J B PruessF C Bennett
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W S GriffinC Araoz
Oct 1, 1986·Annals of Neurology·L E BeckerF Chan
Aug 1, 1988·Histopathology·D M Mann
Jan 1, 1982·Annals of the New York Academy of Sciences·P M Sinet
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R F HarrellL R Ravitz
Jul 1, 1980·Journal of Neuropathology and Experimental Neurology·S TakashimaD L Armstrong
Jun 1, 1994·Journal of Intellectual Disability Research : JIDR·S TakashimaM Arima
Jun 1, 1997·Journal of Intellectual Disability Research : JIDR·N SchupfB Levin
Oct 6, 1997·Neuroscience Letters·R J SiareyZ Galdzicki
Jul 1, 1997·Journal of Geriatric Psychiatry and Neurology·D S GeldmacherP J Whitehouse
Feb 26, 1998·American Journal of Mental Retardation : AJMR·M J Guralnick
Apr 13, 1999·Lancet·P S KishnaniK R Krishnan
Apr 14, 1999·Biological Trace Element Research·I BucciF Monaco
Nov 4, 2000·Expert Opinion on Investigational Drugs·A C Granholm
Feb 7, 2001·Genes & Development·S M ElbashirT Tuschl
Feb 13, 2001·Journal of Intellectual Disability Research : JIDR·G B SeltzerH S Wu
Mar 27, 2001·Journal of Developmental and Behavioral Pediatrics : JDBP·G T Capone
Jun 12, 2001·Medical Hypotheses·J F Turrens
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·N J CaplenR A Morgan
Oct 20, 2001·Mechanisms of Ageing and Development·P SchubertS Ferroni
Mar 13, 2002·Seizure : the Journal of the British Epilepsy Association·Baldev K Singh, Sheryl White-Scott
Apr 18, 2002·Genes & Development·Patrick J PaddisonDouglas S Conklin
Aug 6, 2002·Pediatric Neurology·Mario VuksićIvica Kostović
Sep 24, 2002·Nature Biotechnology·Haibin XiaBeverly L Davidson
Oct 3, 2002·Nature Reviews. Genetics·Michael T McManus, Phillip A Sharp
Oct 11, 2002·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Michael Salman
Nov 5, 2002·Methods : a Companion to Methods in Enzymology·Takashi OkadaKeiya Ozawa
Dec 21, 2002·American Journal of Medical Genetics. Part a·James H HellerPriya S Kishnani
Mar 11, 2003·Child Development·Bruce F PenningtonLynn Nadel

❮ Previous
Next ❯

Citations

Apr 6, 2006·Behavior Genetics·Pierre L Roubertoux, Bernard Kerdelhué
Jan 1, 2011·Occupational Therapy in Health Care·Lisa A Daunhauer, Deborah J Fidler
Feb 2, 2011·Pediatric Clinics of North America·Joseph L Calles
Nov 26, 2010·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·Roswitha B Davies
Nov 21, 2007·Pediatric Neurology·Michael V MilesStephanie L Hotze
Sep 18, 2009·Developmental Medicine and Child Neurology·Tanya RihtmanAsher Ornoy
Jul 9, 2009·Physiological Reviews·Mara DierssenXavier Estivill

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.